Soluble Collectin 11 (CL-11) Acts as an Immunosuppressive Molecule Potentially Used by Stem Cell-Derived Retinal Epithelial Cells to Modulate T Cell Response.
Collectin 11
T cell activation
stem cell-derived retinal pigment epithelium cells
transplantation
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
07 Jul 2023
07 Jul 2023
Historique:
received:
12
05
2023
revised:
30
06
2023
accepted:
04
07
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Retinal pigment epithelium (RPE) cell allotransplantation is seen as a possible solution to retinal diseases. However, the RPE-complement system triggered by the binding of collectin-11 (CL-11) is a potential barrier for RPE transplantation as the complement-mediated inflammatory response may promote T cell recognition. To address this, we investigated the role of CL-11 on T cell immuno-response. We confirmed that RPE cells up-regulated MHC class I and expressed MHC class II molecules in an inflammatory setting. Co-cultures of RPE cells with T cells led to the inhibition of T cell proliferation. We found that CL-11 was partially responsible for this effect as T cell binding of CL-11 inhibited T cell proliferation in association with the downregulation of CD28. We also found that the suppressive action of CL-11 was abrogated in the presence of the RGD peptide given to block the T cell binding of CL-11 by its collagen-like domain. Because RPE cells can bind and secrete CL-11 under stress conditions, we postulate that soluble CL-11 contributes to the immunosuppressive properties of RPE cells. The investigation of this dual biological activity of CL-11, namely as a trigger of the complement cascade and a modulator of T cell responses, may provide additional clues about the mechanisms that orchestrate the immunogenic properties of RPE cells.
Identifiants
pubmed: 37443840
pii: cells12131805
doi: 10.3390/cells12131805
pmc: PMC10341155
pii:
doi:
Substances chimiques
Collectins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : (MR/S020934/1)
Pays : United Kingdom
Références
Cell Rep. 2018 Jul 31;24(5):1151-1162
pubmed: 30067972
Stem Cell Reports. 2016 Oct 11;7(4):619-634
pubmed: 27641646
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3473-81
pubmed: 19168900
Am J Ophthalmol. 1986 May 15;101(5):584-90
pubmed: 3518466
Innate Immun. 2021 Jan;27(1):50-60
pubmed: 33241978
J Clin Invest. 2016 May 2;126(5):1911-25
pubmed: 27088797
Cell Rep. 2019 Nov 26;29(9):2835-2848.e4
pubmed: 31775049
PLoS Pathog. 2012;8(7):e1002793
pubmed: 22792067
PLoS Biol. 2021 Apr 26;19(4):e3001199
pubmed: 33901179
EMBO J. 2001 Apr 2;20(7):1593-604
pubmed: 11285224
Exp Eye Res. 2013 Jul;112:93-101
pubmed: 23644095
Stem Cell Reports. 2018 Sep 11;11(3):681-695
pubmed: 30122442
Nat Rev Immunol. 2009 Oct;9(10):729-40
pubmed: 19730437
J Innate Immun. 2013;5(3):242-50
pubmed: 23220946
Stem Cell Reports. 2016 Oct 11;7(4):635-648
pubmed: 27641649
Prog Retin Eye Res. 2010 Mar;29(2):95-112
pubmed: 19961953
Nat Genet. 2013 Apr;45(4):433-9, 439e1-2
pubmed: 23455636
Front Immunol. 2019 May 17;10:1081
pubmed: 31156634
Cells. 2021 Dec 22;11(1):
pubmed: 35011586
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2862-70
pubmed: 19182257
Exp Eye Res. 2012 Jan;94(1):32-40
pubmed: 22116001
Invest Ophthalmol Vis Sci. 2015 Jan 20;56(2):1051-62
pubmed: 25604685
Immunol Rev. 2023 Jan;313(1):320-326
pubmed: 36200881
Genomics. 2015 May;105(5-6):253-64
pubmed: 25645700
Pediatr Nephrol. 2021 May;36(5):1065-1073
pubmed: 32472330
J Immunol. 2004 Jun 1;172(11):6587-97
pubmed: 15153473
Trends Immunol. 2009 Jul;30(7):306-12
pubmed: 19540809
Nat Rev Immunol. 2003 Nov;3(11):879-89
pubmed: 14668804
Clin Dev Immunol. 2012;2012:925135
pubmed: 22474485
Exp Eye Res. 2011 Mar;92(3):180-8
pubmed: 21255569
Biomaterials. 2011 Jun;32(18):4205-10
pubmed: 21515168
Int J Mol Sci. 2020 Sep 05;21(18):
pubmed: 32899567
Invest Ophthalmol Vis Sci. 2012 Dec 19;53(13):8472-80
pubmed: 23150618
Annu Rev Immunol. 2018 Apr 26;36:309-338
pubmed: 29677470
In Vitro Cell Dev Biol Anim. 1995 May;31(5):330-3
pubmed: 7633668
Front Immunol. 2012 Sep 21;3:296
pubmed: 23049533
J Innate Immun. 2017;9(6):529-545
pubmed: 28772263
Exp Eye Res. 2006 Dec;83(6):1459-71
pubmed: 16996057
FASEB J. 2017 Jun;31(6):2405-2417
pubmed: 28209773
J Immunother. 2016 Oct;39(8):306-15
pubmed: 27548033
Cell. 2003 Oct 3;115(1):13-23
pubmed: 14531999
Exp Eye Res. 2007 Apr;84(4):635-45
pubmed: 17292886
J Immunol. 2008 Dec 1;181(11):7525-36
pubmed: 19017942
Exp Eye Res. 2008 Dec;87(6):543-50
pubmed: 18926817
Front Immunol. 2017 Nov 03;8:1467
pubmed: 29163534
Sci Rep. 2017 Nov 7;7(1):14625
pubmed: 29116192
Trends Immunol. 2015 Jun;36(6):354-63
pubmed: 25981967
FASEB J. 2020 Jan;34(1):822-834
pubmed: 31914693
Adv Exp Med Biol. 2019;1189:3-23
pubmed: 31758529
Ocul Immunol Inflamm. 1997 Mar;5(1):43-50
pubmed: 9145692
Oncoimmunology. 2017 Jul 5;6(10):e1345402
pubmed: 29123956
Semin Immunopathol. 2008 Apr;30(2):85-95
pubmed: 18299835
J Cell Physiol. 2009 Jul;220(1):119-28
pubmed: 19277984
Immunobiology. 2012 Sep;217(9):851-63
pubmed: 22475410
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
Int J Inflam. 2013;2013:348092
pubmed: 23762772
Invest Ophthalmol Vis Sci. 2013 May 07;54(5):3240-9
pubmed: 23532521
PLoS One. 2014 Apr 04;9(4):e93343
pubmed: 24705166
Nat Commun. 2020 Mar 30;11(1):1609
pubmed: 32231223
Nat Cell Biol. 2006 Nov;8(11):1270-6
pubmed: 17060905
Nat Genet. 2013 Nov;45(11):1366-70
pubmed: 24036952
Nat Rev Nephrol. 2016 Jul;12(7):378
pubmed: 27140851
Mucosal Immunol. 2010 May;3(3):239-46
pubmed: 20200511
J Immunol. 2010 Nov 15;185(10):6096-104
pubmed: 20956340
J Immunol. 2006 Aug 1;177(3):1721-8
pubmed: 16849481